Delta 9 Cannabis Inc. is a Canadian licensed producer of cannabis products under the Cannabis Act. Founded in 2017 and headquartered in Winnipeg, Manitoba, the company has established integrated operations spanning cultivation, processing, and retail. Delta 9 holds Health Canada licenses for controlled production and distribution, and it markets a diversified portfolio that includes dried flower, pre-rolls, extracts, oils, vapes and edibles.
On the cultivation front, Delta 9 operates indoor and greenhouse facilities designed to optimize yield and consistency. The company’s in-house manufacturing arm, CHRONARIS, is responsible for extraction, formulation and packaging, supporting the development of value-added products such as gummies, beverages, cartridges and capsules. Delta 9 has invested in quality-control protocols and proprietary strain development to differentiate its product lineup in a competitive market.
Delta 9 has also built a retail network of Delta 9 Cannabis Stores across Manitoba and Saskatchewan, complemented by an e-commerce platform for online ordering and home delivery within its licensed provinces. Its retail footprint is supported by localized marketing initiatives, community outreach and compliance-focused training programs for store staff, reinforcing the company’s commitment to safe and responsible cannabis access.
Under the leadership of President and CEO David Dauk, Delta 9 Cannabis has pursued strategic growth through acquisitions, supply agreements and brand collaborations. The management team includes executives with backgrounds in agriculture, consumer packaged goods and regulatory compliance, guiding the company’s expansion efforts and product innovation roadmap in Canada’s regulated adult-use and medical markets.
AI Generated. May Contain Errors.
Free DLTNF Stock Alerts